InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.10
(
-0.07%
)
US TECH 100
19,236.44
(
-0.12%
)
Dow Jones
39,158.47
(
0.06%
)
Brent Oil
84.32
(
-0.81%
)
Bitcoin
63,625.00
(
-1.84%
)
Post# of 113866
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

micham2012

Send PM Follow Ignore
Followers 23
Posts 1226
Boards Moderated 0
Alias Born 03/22/2005

micham2012

Re: CPTMatt post# 34318

Sunday, 04/23/2017 7:14:35 AM

Sunday, April 23, 2017 7:14:35 AM

Post# of 113866
CNAT:

Still holding 70% of shares. Sold 30% at $7.65.

Roth Capital has increased price target from $4 to $12:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=130702786

And, encouraging data reported last week:

http://ih.advfn.com/p.php?pid=nmona&article=74387481

If CNAT crosses $10, does it become eligible for biotech fund buying?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up